In addition to the targeting effect of LDP 14 on brain endothelial cells, the interaction of this peptide with human U87 glioma cells was also assessed in comparison with four well-known BBB targeting peptides including SRLL, SRLC, TGN, and Lep 30. This evidence concerns the gene TG and central nervous system cancer.